Saturday, November 14, 2026

USD/EUR Bearish By 1% In The Last 21 Sessions

Automated market report from our archive (2020–2024), published before source-traceability. How we work

USD/EUR Bearish By 1% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.73% for the last 21 sessions. At 19:05 EST on Sunday, 30 April, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 0.71% up from its 52-week low and 13.394% down from its 52-week high.

News about

  • Usd/jpy price analysis: trades nearby six-week highs, above 136.20s. According to FXStreet on Saturday, 29 April, "The first resistance would be the March 10 high at 136.99, which, once cleared, the USD/JPY will continue towards the March 9 high at 137.35. ", "A breach of the latter, the USD/JPY could dip toward April 19 daily high, turned support at 135.13, ahead of challenging the 135.00 figure."
  • Usd/jpy price analysis: rally inspired by continuation of boj’s ultra-dovish policy approaches 135.00. According to FXStreet on Friday, 28 April, "The USD/JPY pair has scaled quickly to near the crucial resistance of 135.00 after the Bank of Japan (BoJ) announced a continuation of ultra-loose monetary policy and stability in Japanese Government Bonds' (JGBs) yields band to maintain an expansionary policy stance. ", "On a four-hour scale, USD/JPY is near the edge of the horizontal resistance of the Ascending Triangle chart pattern plotted from March 15 high at 135.12. "
  • Usd/jpy jumps 100 pips to mid-134.00s on boj status quo, governor ueda eyed. According to FXStreet on Friday, 28 April, "However, challenges to sentiment emanating from the First Republic Bank (FRB), US debt ceiling expiration woes and hawkish Fed bets led by recently upbeat US inflation signals seem to prod the USD/JPY pair buyers.", "However, the BoJ also said that they will take additional easing steps without hesitation as needed while striving for market stability, which in turn propels the USD/JPY prices of late."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com